H2 influenza viruses: designing vaccines against future H2 pandemics.
Identifieur interne : 000003 ( 1968/Analysis ); précédent : 000002; suivant : 000004H2 influenza viruses: designing vaccines against future H2 pandemics.
Auteurs : Z Beau Reneer [États-Unis] ; Ted M. Ross [États-Unis]Source :
- Biochemical Society transactions [ 1470-8752 ] ; 2019.
Descripteurs français
- KwdFr :
- Acide N-acétyl-neuraminique (métabolisme), Animaux, Glycoprotéine hémagglutinine du virus influenza (), Glycoprotéine hémagglutinine du virus influenza (métabolisme), Grippe chez les oiseaux (), Grippe chez les oiseaux (épidémiologie), Grippe humaine (), Grippe humaine (immunologie), Grippe humaine (transmission), Humains, Oiseaux, Pandémies (), Sites de fixation, Sous-type H2N2 du virus de la grippe A (immunologie), Suidae, Vaccins antigrippaux (biosynthèse).
- MESH :
- biosynthèse : Vaccins antigrippaux.
- immunologie : Grippe humaine, Sous-type H2N2 du virus de la grippe A.
- métabolisme : Acide N-acétyl-neuraminique, Glycoprotéine hémagglutinine du virus influenza.
- épidémiologie : Grippe chez les oiseaux, Grippe humaine.
- Animaux, Glycoprotéine hémagglutinine du virus influenza, Grippe chez les oiseaux, Grippe humaine, Humains, Oiseaux, Pandémies, Sites de fixation, Suidae.
English descriptors
- KwdEn :
- Animals, Binding Sites, Birds, Hemagglutinin Glycoproteins, Influenza Virus (chemistry), Hemagglutinin Glycoproteins, Influenza Virus (metabolism), Humans, Influenza A Virus, H2N2 Subtype (immunology), Influenza Vaccines (biosynthesis), Influenza in Birds (epidemiology), Influenza in Birds (prevention & control), Influenza, Human (immunology), Influenza, Human (prevention & control), Influenza, Human (transmission), N-Acetylneuraminic Acid (metabolism), Pandemics (prevention & control), Swine.
- MESH :
- chemical , biosynthesis : Influenza Vaccines.
- chemical , chemistry : Hemagglutinin Glycoproteins, Influenza Virus.
- chemical , metabolism : Hemagglutinin Glycoproteins, Influenza Virus, N-Acetylneuraminic Acid.
- epidemiology : Influenza in Birds.
- immunology : Influenza A Virus, H2N2 Subtype, Influenza, Human.
- prevention & control : Influenza in Birds, Influenza, Human, Pandemics.
- transmission : Influenza, Human.
- Animals, Binding Sites, Birds, Humans, Swine.
Abstract
Influenza-related pathologies affect millions of people each year and the impact of influenza on the global economy and in our everyday lives has been well documented. Influenza viruses not only infect humans but also are zoonotic pathogens that infect various avian and mammalian species, which serve as viral reservoirs. While there are several strains of influenza currently circulating in animal species, H2 influenza viruses have a unique history and are of particular concern. The 1957 'Asian Flu' pandemic was caused by H2N2 influenza viruses and circulated among humans from 1957 to 1968 before it was replaced by viruses of the H3N2 subtype. This review focuses on avian influenza viruses of the H2 subtype and the role these viruses play in human infections. H2 influenza viral infections in humans would present a unique challenge to medical and scientific researchers. Much of the world's population lacks any pre-existing immunity to the H2N2 viruses that circulated 50-60 years ago. If viruses of this subtype began circulating in the human population again, the majority of people alive today would have no immunity to H2 influenza viruses. Since H2N2 influenza viruses have effectively circulated in people in the past, there is a need for additional research to characterize currently circulating H2 influenza viruses. There is also a need to stockpile vaccines that are effective against both historical H2 laboratory isolates and H2 viruses currently circulating in birds to protect against a future pandemic.
DOI: 10.1042/BST20180602
PubMed: 30647144
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000011
- to stream PubMed, to step Curation: 000011
- to stream PubMed, to step Checkpoint: 000008
- to stream Ncbi, to step Merge: 000F53
- to stream Ncbi, to step Curation: 000F53
- to stream Ncbi, to step Checkpoint: 000F53
- to stream Main, to step Merge: 000087
- to stream Main, to step Curation: 000087
- to stream Main, to step Exploration: 000087
- to stream 1968, to step Extraction: 000003
Links to Exploration step
pubmed:30647144Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">H2 influenza viruses: designing vaccines against future H2 pandemics.</title><author><name sortKey="Reneer, Z Beau" sort="Reneer, Z Beau" uniqKey="Reneer Z" first="Z Beau" last="Reneer">Z Beau Reneer</name><affiliation wicri:level="1"><nlm:affiliation>Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, U.S.A.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602</wicri:regionArea><wicri:noRegion>GA 30602</wicri:noRegion></affiliation></author><author><name sortKey="Ross, Ted M" sort="Ross, Ted M" uniqKey="Ross T" first="Ted M" last="Ross">Ted M. Ross</name><affiliation wicri:level="1"><nlm:affiliation>Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, U.S.A. tedross@uga.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602</wicri:regionArea><wicri:noRegion>GA 30602</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:30647144</idno><idno type="pmid">30647144</idno><idno type="doi">10.1042/BST20180602</idno><idno type="wicri:Area/PubMed/Corpus">000011</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000011</idno><idno type="wicri:Area/PubMed/Curation">000011</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000011</idno><idno type="wicri:Area/PubMed/Checkpoint">000008</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000008</idno><idno type="wicri:Area/Ncbi/Merge">000F53</idno><idno type="wicri:Area/Ncbi/Curation">000F53</idno><idno type="wicri:Area/Ncbi/Checkpoint">000F53</idno><idno type="wicri:Area/Main/Merge">000087</idno><idno type="wicri:Area/Main/Curation">000087</idno><idno type="wicri:Area/Main/Exploration">000087</idno><idno type="wicri:Area/1968/Extraction">000003</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">H2 influenza viruses: designing vaccines against future H2 pandemics.</title><author><name sortKey="Reneer, Z Beau" sort="Reneer, Z Beau" uniqKey="Reneer Z" first="Z Beau" last="Reneer">Z Beau Reneer</name><affiliation wicri:level="1"><nlm:affiliation>Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, U.S.A.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602</wicri:regionArea><wicri:noRegion>GA 30602</wicri:noRegion></affiliation></author><author><name sortKey="Ross, Ted M" sort="Ross, Ted M" uniqKey="Ross T" first="Ted M" last="Ross">Ted M. Ross</name><affiliation wicri:level="1"><nlm:affiliation>Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, U.S.A. tedross@uga.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602</wicri:regionArea><wicri:noRegion>GA 30602</wicri:noRegion></affiliation></author></analytic><series><title level="j">Biochemical Society transactions</title><idno type="eISSN">1470-8752</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Binding Sites</term><term>Birds</term><term>Hemagglutinin Glycoproteins, Influenza Virus (chemistry)</term><term>Hemagglutinin Glycoproteins, Influenza Virus (metabolism)</term><term>Humans</term><term>Influenza A Virus, H2N2 Subtype (immunology)</term><term>Influenza Vaccines (biosynthesis)</term><term>Influenza in Birds (epidemiology)</term><term>Influenza in Birds (prevention & control)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Influenza, Human (transmission)</term><term>N-Acetylneuraminic Acid (metabolism)</term><term>Pandemics (prevention & control)</term><term>Swine</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acide N-acétyl-neuraminique (métabolisme)</term><term>Animaux</term><term>Glycoprotéine hémagglutinine du virus influenza ()</term><term>Glycoprotéine hémagglutinine du virus influenza (métabolisme)</term><term>Grippe chez les oiseaux ()</term><term>Grippe chez les oiseaux (épidémiologie)</term><term>Grippe humaine ()</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (transmission)</term><term>Humains</term><term>Oiseaux</term><term>Pandémies ()</term><term>Sites de fixation</term><term>Sous-type H2N2 du virus de la grippe A (immunologie)</term><term>Suidae</term><term>Vaccins antigrippaux (biosynthèse)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Hemagglutinin Glycoproteins, Influenza Virus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Hemagglutinin Glycoproteins, Influenza Virus</term><term>N-Acetylneuraminic Acid</term></keywords><keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza in Birds</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Sous-type H2N2 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H2N2 Subtype</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Acide N-acétyl-neuraminique</term><term>Glycoprotéine hémagglutinine du virus influenza</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza in Birds</term><term>Influenza, Human</term><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe chez les oiseaux</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Binding Sites</term><term>Birds</term><term>Humans</term><term>Swine</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Glycoprotéine hémagglutinine du virus influenza</term><term>Grippe chez les oiseaux</term><term>Grippe humaine</term><term>Humains</term><term>Oiseaux</term><term>Pandémies</term><term>Sites de fixation</term><term>Suidae</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Influenza-related pathologies affect millions of people each year and the impact of influenza on the global economy and in our everyday lives has been well documented. Influenza viruses not only infect humans but also are zoonotic pathogens that infect various avian and mammalian species, which serve as viral reservoirs. While there are several strains of influenza currently circulating in animal species, H2 influenza viruses have a unique history and are of particular concern. The 1957 'Asian Flu' pandemic was caused by H2N2 influenza viruses and circulated among humans from 1957 to 1968 before it was replaced by viruses of the H3N2 subtype. This review focuses on avian influenza viruses of the H2 subtype and the role these viruses play in human infections. H2 influenza viral infections in humans would present a unique challenge to medical and scientific researchers. Much of the world's population lacks any pre-existing immunity to the H2N2 viruses that circulated 50-60 years ago. If viruses of this subtype began circulating in the human population again, the majority of people alive today would have no immunity to H2 influenza viruses. Since H2N2 influenza viruses have effectively circulated in people in the past, there is a need for additional research to characterize currently circulating H2 influenza viruses. There is also a need to stockpile vaccines that are effective against both historical H2 laboratory isolates and H2 viruses currently circulating in birds to protect against a future pandemic.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Reneer, Z Beau" sort="Reneer, Z Beau" uniqKey="Reneer Z" first="Z Beau" last="Reneer">Z Beau Reneer</name></noRegion><name sortKey="Ross, Ted M" sort="Ross, Ted M" uniqKey="Ross T" first="Ted M" last="Ross">Ted M. Ross</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/1968/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000003 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/1968/Analysis/biblio.hfd -nk 000003 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= 1968
|étape= Analysis
|type= RBID
|clé= pubmed:30647144
|texte= H2 influenza viruses: designing vaccines against future H2 pandemics.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/1968/Analysis/RBID.i -Sk "pubmed:30647144" \
| HfdSelect -Kh $EXPLOR_AREA/Data/1968/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |